Ingredients

Nettle Leaf Is Not Nettle Root, And It Matters Here

Reviewed by Dr. Kambiz Tajkarimi, MD

One word on a panel decides whether a whole trial record applies, and almost nobody prints it.

One plant, two medicines

Urtica dioica is the stinging nettle: a common perennial across Europe, Asia and North America, notorious for the hairs on its leaves and stems that deliver a dose of formic-acid-like irritants to anyone who brushes past it.

In herbal medicine it is not one remedy but two, and the split runs along the plant itself. The aerial parts, meaning the leaves and stems, are one preparation. The root is another. They contain different compounds in different proportions, they have been studied in different populations for different conditions, and the evidence for one says almost nothing about the other.

Pharmacopoeias keep them apart for exactly this reason: the Latin names are urticae folium for the leaf and urticae radix for the root. The comprehensive review of nettle root carries that second term in its own title, which is the clearest possible signal that the distinction is not pedantry invented for a blog post.

What nettle root has actually been tested for

The root is the urological one. It has been studied in men with benign prostatic hyperplasia, usually alongside a saw palmetto extract as a fixed combination, and usually at 300 to 600 mg a day.

The 2005 placebo-controlled multicentre trial is the representative example: a long-term, double-blind study of a sabal and urtica combination in men with lower urinary tract symptoms. The urticae radix review covers the wider body of that work and the proposed mechanisms, which involve lignans, sterols and effects on sex-hormone-binding globulin rather than anything hormonal in the way a supplement page usually implies.

It is worth noticing that this is also the literature in which saw palmetto looks strongest. The pairing is not a coincidence of shelf placement; it is how the trials were designed.

What nettle leaf has been tested for

The leaf has its own evidence and it points somewhere else entirely.

The best-known modern work is on inflammatory joint pain, where nettle leaf preparations have been studied topically and orally. Separately, and more relevantly to anybody reading a supplement label, a randomised double-blind placebo-controlled trial in type 2 diabetes tested nettle leaf extract on glycaemic control in patients already on medication.

That second trial is the one worth knowing about if you take this bottle, and not because it is a benefit. It is a reason to mention nettle leaf to anyone adjusting diabetes medication, and it is on the safety page for that reason rather than as a selling point.

Both columns describe real medicines with real evidence. Only one of them is the evidence a men's formula is reaching for when it lists nettle.

Which one this panel carries

Leaf. The Horsewood panel reads Nettle (Urtica dioica) Leaf Extract, 20 mg, and the manufacturer’s own listing graphic says the same thing.

There are two ways to read that and both are worth stating.

The critical reading

This is a men’s formula carrying saw palmetto and nettle, the classic urological pairing, and it has paired saw palmetto with the wrong nettle. The combination trials used root. At 20 mg of leaf, the row cannot be doing the job the pairing implies.

The fair reading

The label says LEAF. It did not have to. A very large number of products in this aisle print nettle with no part at all, which lets a reader assume root and quietly benefit from the urological literature without claiming it. This label closed that door itself, in print, on the panel.

That is a real piece of honesty and it is the same honesty that makes the 20 mg figure checkable in the first place. A label that tells you enough to criticise it is a better document than one that does not.

Why the distinction changes the answer

Consider the question a buyer actually has: does the nettle in this bottle do anything for urinary symptoms?

• If the row were root at 300 mg, the answer would be: possibly, in combination with an adequate saw palmetto extract, on the basis of a real trial record.
• If the row were root at 20 mg, the answer would be: no published basis, same problem as the saw palmetto row.
• The row is leaf at 20 mg, so the answer is: the literature being pointed at does not apply to this ingredient at all, before the amount is even considered.

Three quite different answers, and the only thing separating them is one word on a panel. That is why this article exists.

How to spot this on any label

Nettle is not the only ingredient where the plant part decides whether a literature applies. The habit generalises and it is one of the most useful things a reader can carry into this aisle.

• Nettle: root or leaf
• Ginseng: root, and which species
• Ashwagandha: root or root and leaf
• Maca: root, and which colour
• Saw palmetto: berry, and which extraction
• Epimedium: leaf, and which species
• Tongkat ali: root, and which ratio

Two follow-up questions turn that into a working method. First, does the label name the part? If not, assume the cheapest one. Second, does the literature you have in mind use that part? If not, the amount does not matter, because the evidence is not about this ingredient.

The nine-check version of this is on the checklist page, where naming the plant part is check three.

What a root formula would have looked like

It is worth sketching the alternative, because it shows how far this panel sits from the literature it is standing next to.

A formula built from the combination trials would carry a saw palmetto lipidosterolic extract at 320 mg and a nettle ROOT extract at 240 to 320 mg daily, and it would be aimed at urinary flow and symptom scores rather than at drive. That is roughly what the products used in the placebo-controlled multicentre trials contained, and it is how the urticae radix review describes the material that was tested.

Two of those figures are more than ten times what is on this panel, and the plant part on the nettle row is different. So a fair summary is that this bottle contains the two right plants in the wrong proportions and, on one of them, the wrong part.

Why a formulator might still build it this way

• Cost. 320 mg of a named saw palmetto extract plus 300 mg of nettle root is most of a capsule on its own, and it costs more than five 20 mg rows put together.
• Room. Seven rows totalling 118 mg fit comfortably beside a filler. Seven rows totalling 700 mg would need two capsules for the botanicals alone, before the shell and the flow agent.
• Recognition. Seven familiar names read as a fuller formula than two adequate ones, whatever the arithmetic says, and a panel is read in about four seconds.

None of that is a scandal. It is the ordinary economics of this shelf, and the only reason you can see it operating here is that the panel printed its numbers.

The verdict

The nettle row on this panel is honest and weak, in that order. It prints the plant part, which most of the aisle does not, and the part it prints is the one whose literature has little to say about why a man would buy this bottle.

It is a useful row for a different reason: it tells you something about how the formula was assembled. A panel carrying saw palmetto berry at 20 mg and nettle LEAF at 20 mg was not built from the combination trials. It was built from a list of recognisable names. Knowing that is worth more than any single milligram figure on it.

The whole panel is transcribed on the label page and every row is set against its own research on the ingredients page.